Thermo Fisher to acquire Brammer Bio in $1.7 billion gene-therapy deal
March 24, 2019 at 19:03 PM EDT
Thermo Fisher Scientific Inc. said it is buying Brammer Bio for $1.7 billion in a move that would expand the lab-equipment company’s presence in the rapidly growing field of gene therapy.
